PP7

CAS No. 433238-84-7

PP7( —— )

Catalog No. M26391 CAS No. 433238-84-7

PP7 is a potent inhibitor of PB1-PB2 interaction(IC50 of 8.6 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 187 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1107 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PP7
  • Note
    Research use only, not for human use.
  • Brief Description
    PP7 is a potent inhibitor of PB1-PB2 interaction(IC50 of 8.6 μM).
  • Description
    PP7 is a potent inhibitor of PB1-PB2 interaction(IC50 of 8.6 μM).(In Vitro):PP7 showed inhibition against viral polymerase activity (IC50=9.5 μM). PP7 exhibited antiviral activities against influenza virus subtypes A (H1N1)pdm09(EC50=1.4 μM), A(H7N9) and A(H9N2) in cell cultures.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Influenza Virus
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    433238-84-7
  • Formula Weight
    377.22
  • Molecular Formula
    C18H14Cl2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOc1ccc(\C=C2/C(=O)NN(C2=O)c2ccc(Cl)c(Cl)c2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sole R, Gatto V, Conca S, Bardella N, Morandini A, Beghetto V. Sustainable Triazine-Based Dehydro-Condensation Agents for Amide Synthesis. Molecules. 2021 Jan 2;26(1):191.
molnova catalog
related products
  • RO-7

    RO-7 is a novel small molecule, broad-spectrum inhibitor of influenza acidic polymerase (PA) protein endonuclease activity with EC50 of 3.2-16 nM in MDCK cells.

  • Molnupiravir

    Molnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability.

  • Pimodivir

    Pimodivir (VX-787, JNJ872, JNJ 63623872) is a first-in-class, orally bioavailable inhibitor of influenza virus polymerase PB2 subunit with Kd of <3 nM, CPE EC50 of 2 nM.